Please login to the form below
Therapy Watch expands its oncology portfolio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.
Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Guide
- How to embrace behavioural science principles in healthcare MR
Research Partnership
- Article
- A glimmer of hope for Alzheimer’s patients, but at what cost?
Research Partnership
- Video
- Virtual Conference Live
Research Partnership
- Report
- Digital Health Tools - Physician Trends
Research Partnership
- Webcast
- Oncology landscape: How innovative market research methods can navigate you to success
Research Partnership
- Article:
- The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership
